Abilify MyCite for treating bipolar disorder 1 or schizophrenia [ID3833]Status:Topic prioritisationProgramme:Technology appraisal guidanceExpected publication date: TBC
Severe and enduring mental illness guidance reviewStatus:In developmentProgramme:NICE guidelineExpected publication date: TBC